Join Julia Brown, PharmD, a pediatric hematology/oncology pharmacist, and Lydia Benitez, an adult leukemia pharmacist, as they dive into the evolving landscape of blinatumomab in acute lymphoblastic leukemia (ALL). They discuss the impactful findings of the AALL1731 trial and ECOG-1910, shedding light on improved survival rates. The conversation touches on practical challenges like home infusion, patient monitoring strategies, and the exciting potential of subcutaneous formulations, all while emphasizing equitable access for vulnerable populations.
